Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Fresenius Medical Care AG & Co. KGaA (ETR:FME) is a favorite amongst institutional investors who own 44%

In This Article:

Key Insights

  • Given the large stake in the stock by institutions, Fresenius Medical Care KGaA's stock price might be vulnerable to their trading decisions

  • 51% of the business is held by the top 5 shareholders

  • Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company

A look at the shareholders of Fresenius Medical Care AG & Co. KGaA (ETR:FME) can tell us which group is most powerful. With 44% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.

In the chart below, we zoom in on the different ownership groups of Fresenius Medical Care KGaA.

See our latest analysis for Fresenius Medical Care KGaA

ownership-breakdown
XTRA:FME Ownership Breakdown May 4th 2023

What Does The Institutional Ownership Tell Us About Fresenius Medical Care KGaA?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Fresenius Medical Care KGaA already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Fresenius Medical Care KGaA's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
XTRA:FME Earnings and Revenue Growth May 4th 2023

We note that hedge funds don't have a meaningful investment in Fresenius Medical Care KGaA. Fresenius SE & Co. KGaA is currently the company's largest shareholder with 32% of shares outstanding. For context, the second largest shareholder holds about 9.3% of the shares outstanding, followed by an ownership of 3.6% by the third-largest shareholder.

Our research also brought to light the fact that roughly 51% of the company is controlled by the top 5 shareholders suggesting that these owners wield significant influence on the business.